Antimicrobial resistance of 36 strains of Helicobacter pylori in adolescents.
- Author:
	        		
		        		
		        		
			        		Lie-Ping HUANG
			        		
			        		
			        		
			        			1
			        			,
			        		
			        			2
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Man-Li ZHUANG
			        		
			        		;
		        		
		        		
		        		
			        		Cheng-Ping GU
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Journal Article
 - MeSH: Adolescent; Amoxicillin; pharmacology; Anti-Infective Agents; pharmacology; Child; Clarithromycin; pharmacology; Drug Resistance, Bacterial; Female; Gastroscopy; Helicobacter pylori; drug effects; Humans; Levofloxacin; Male; Metronidazole; pharmacology; Microbial Sensitivity Tests; Ofloxacin; pharmacology
 - From: Chinese Journal of Contemporary Pediatrics 2009;11(3):210-212
 - CountryChina
 - Language:Chinese
 - 
		        	Abstract:
			       	
			       		
				        
				        	
OBJECTIVETo investigate the resistance of Helicobacter pylori (H. pylori) to antimicrobial agents in adolescents.
METHODSOne hundred and eight adolescents (6-18 years old) underwent a gastroscopy examination. H. pylori strains were isolated from gastric mucosa. Antimicrobial susceptibility testing was performed by means of Kirby-Baner.
RESULTSThirty-six H. pylori strains were identified. The resistant rate of H. pylori strains to clarithromycin, fruranzolidone and amoxicillin was 8.3%, 16.7% and 33.3%, respectively. H. pylori strains showed a high resistance to metronidazole (94.4%), while no strain was resistant to gentamicin and levofloxacin.
CONCLUSIONSThe H. pylori strains from the adolescents in Zhejiang showed a high resistance to metronidazole and amoxicillin but a low resistance to clarithromycin and fruranzolidone. All of H. pylori strains were susceptive to gentamicin and levofloxacin.
 
            